Alpha Teknova, Inc. voted to appoint Ms. Martha J. Demski to serve as a member of the Board, effective August 31, 2023, to fill the vacancy created by the pending resignation from the Board of Mr. Robert E. McNamara, which will occur on the same day. Ms. Demski will serve on the Board as a Class I Director until the Company?s 2025 annual meeting of stockholders. The Board has also voted to appoint Ms. Demski to serve as a member of the Compensation Committee of the Board and as Chair of the Audit Committee of the Board .

The Board decided upon Ms. Demski?s appointment after receiving a nomination and recommendation from the Board?s Nominating and Corporate Governance Committee. The Board has determined that Ms. Demski qualifies as ?independent? in accordance with the applicable listing requirements of The Nasdaq Stock Market LLC and satisfies the independence requirements applicable to Audit Committee members under Rule 10A-3 of the Securities Exchange Act of 1934, as amended.

The Board has also determined that Ms. Demski qualifies as an ?audit committee financial expert? within the meaning of the regulations of the Securities and Exchange Commission and can read and understand fundamental financial statements in accordance with applicable requirements. Ms. Demski has extensive strategic and operational leadership expertise in biotech and finance.

Ms. Demski has public company board expertise across various roles including as chair of the board of directors, audit committee chair, and compensation committee member, having served on the boards of several publicly traded companies, including Chimerix, Inc., Equillium, Inc., and ADMA Biologics, Inc. . Ms. Demski also has executive and operating experience at numerous companies, including as a chief financial officer and chief operating officer. In addition to her public company experience, Ms. Demski has served as a board member and advisor to various private companies and philanthropic organizations.

There are no family relationships between Ms. Demski and any director or executive officer of the Company and she was not selected by the Board to serve as a director pursuant to any arrangement or understanding with any person. Ms. Demski has not engaged in any transaction that would be reportable as a related party transaction under Item 404(a) of Regulation S-K.